Your browser doesn't support javascript.
loading
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI).
Khanna, Sahil; Sims, Matthew; Louie, Thomas J; Fischer, Monika; LaPlante, Kerry; Allegretti, Jessica; Hasson, Brooke R; Fonte, Allyson T; McChalicher, Christopher; Ege, David S; Bryant, Jessica A; Straub, Timothy J; Ford, Christopher B; Henn, Matthew R; Wang, Elaine E L; von Moltke, Lisa; Wilcox, Mark H.
Afiliação
  • Khanna S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
  • Sims M; Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont, Royal Oak, MI 48073, USA.
  • Louie TJ; Department of Internal Medicine and Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI 48309, USA.
  • Fischer M; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
  • LaPlante K; Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN 46202, USA.
  • Allegretti J; Department of Pharmacy Practice, University of Rhode Island, Kingston, RI 02881, USA.
  • Hasson BR; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
  • Fonte AT; Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • McChalicher C; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Ege DS; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Bryant JA; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Straub TJ; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Ford CB; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Henn MR; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Wang EEL; Seres Therapeutics, Cambridge, MA 02139, USA.
  • von Moltke L; Seres Therapeutics, Cambridge, MA 02139, USA.
  • Wilcox MH; Seres Therapeutics, Cambridge, MA 02139, USA.
Antibiotics (Basel) ; 11(9)2022 Sep 10.
Article em En | MEDLINE | ID: mdl-36140013

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article